ArticleAntibiotics (Basel, Switzerland)2020
Phage Therapy, Lysin Therapy, and Antibiotics: A Trio Due to Come.
Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Overcoming phage resistance: efficacy of sequential phage-colistin therapy against carbapenem-resistantMicrobiology spectrum · 2025Article
- Article
- A Novel Truncated CHAP Modular Endolysin, CHAPJournal of microbiology and biotechnology · 2024Article
- Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives.Gut pathogens · 2023Review
- Phage Therapy vs. the Use of Antibiotics in the Treatment ofAntibiotics (Basel, Switzerland) · 2022Article
- Article
- Engineered endolysin-based "artilysins" for controlling the gram-negative pathogen Helicobacter pylori.AMB Express · 2021Article
- Preclinical data and safety assessment of phage therapy in humans.Current opinion in biotechnology · 2021Review
- Antibacterial Effects of Recombinant Endolysins in Disinfecting Medical Equipment: A Pilot Study.Frontiers in microbiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since their introduction, at the beginning of the 20th century, antibiotics were regarded as "magic-bullets", a term coined by Paul Ehrlich, and, for several decades, considered as the universal panacea to combat pathogenic and/or undesirable bacteria [...].
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.